日本在线观看不卡,国产成人免费观看,国产gaysex男同视频chinese,欧美一级www

樹人論文網(wǎng)一個專業(yè)的學(xué)術(shù)咨詢網(wǎng)站!!!
樹人論文網(wǎng)
學(xué)術(shù)咨詢服務(wù)

Science Translational Medicine

來源: 樹人論文網(wǎng) 瀏覽次數(shù):397次
創(chuàng)刊時間:2009
周期:Weekly
ISSN:1946-6234
影響因子:17.161
是否開源:No
年文章量:228
錄用比:很難
學(xué)科方向:細(xì)胞生物學(xué)
研究方向:生物
通訊地址:AMER ASSOC ADVANCEMENT SCIENCE, 1200 NEW YORK AVE, NW, WASHINGTON, USA, DC, 20005
官網(wǎng)地址:http://stm.sciencemag.org/
投稿地址:https://cts.sciencemag.org/scc/login.html
網(wǎng)友分享經(jīng)驗:約1.0個月

Science Translational Medicine雜志中文介紹

《科學(xué)轉(zhuǎn)化醫(yī)學(xué)》是一份致力于轉(zhuǎn)化醫(yī)學(xué)領(lǐng)域的研究和熱點問題的周刊。適合提交的轉(zhuǎn)化醫(yī)學(xué)主題包括任何使該領(lǐng)域更接近改善人類健康或疾病診斷和治療目標(biāo)的原創(chuàng)研究成果、討論或分析。特別鼓勵跨學(xué)科的方法,例如在工程和診斷學(xué)、化學(xué)和藥物開發(fā)、或細(xì)胞生物學(xué)和臨床醫(yī)學(xué)方面進(jìn)行研究。我們接受原創(chuàng)研究,以及評論、觀點和評論。該雜志的一個主要目標(biāo)是發(fā)表論文,在基礎(chǔ)研究和人類應(yīng)用的結(jié)合點發(fā)現(xiàn)并填補科學(xué)知識的空白。在這方面,發(fā)表在《科學(xué)轉(zhuǎn)化醫(yī)學(xué)》(Science Translational Medicine)上的原始研究應(yīng)該報告在疾病預(yù)防、診斷或治療方面的重大進(jìn)展;為未來在轉(zhuǎn)化醫(yī)學(xué)領(lǐng)域的探索和投資提供模板;改變我們對人類生物學(xué)的理解;在處理特定問題的概念方法上極具創(chuàng)新性;或推動探索改善人類健康的新方向。這些論文最好能提供超越其研究領(lǐng)域的見解和證據(jù)。最后,我們將發(fā)表符合嚴(yán)格的優(yōu)秀和創(chuàng)新標(biāo)準(zhǔn)的論文,同時為作者提供及時、專業(yè)的編輯和同行評審。

Science Translational Medicine雜志英文介紹

Science Translational Medicine is a weekly journal devoted to research and issues of strong interest to the translational medicine community. Translational medicine topics suitable for submission include any original research findings, discussions or analyses that move the field closer to the goal of improving human health, or the diagnosis and treatment of disease. Interdisciplinary approaches are particularly encouraged, for example, studies at the interface of engineering and diagnostics, chemistry and drug development, or cell biology and clinical medicine. We accept original research, as well as Reviews, Perspectives and Commentaries.A major goal of the journal is to publish papers that identify and fill scientific knowledge gaps at the junction of basic research and human applications. In this vein, original research published in Science Translational Medicine should report significant progress toward the prevention, diagnosis, or treatment of disease; serve as templates for future explorations and investments in the field of translational medicine; transform our understanding of human biology; be exceptionally innovative in its conceptual approach to a given problem; or catalyze new directions of explorations toward improved human health. These papers preferably will provide insights and evidence with influence beyond their own fields of research. Finally, we will publish papers that meet rigorous criteria of excellence and innovation, while providing authors with prompt and expert editing and peer review.

Science Translational Medicine影響因子